EFFICACY OF ANTIVIRAL THERAPY IN LIVER TRANSPLANT RECIPIENTS WITH RECURRENT HEPATITIS C: IMPACT OF DONOR AGE, GENOTYPE AND VIRAL KINETICS

被引：0
|
作者：
Aguilera, Victoria [1 ,2 ]
Rubin, Angel [1 ,2 ]
Prieto, Martin [1 ,2 ]
Risalde, Blas [1 ,2 ]
Ortiz, Cecilia [2 ,3 ]
Melero, Josep L. [1 ]
Berenguer, Marina [1 ,2 ]
机构：
[1] Hosp La Fe, Hepatol Dept, E-46009 Valencia, Spain
[2] Hlth Inst Carlos III, Ciberehd, Valencia, Spain
[3] Hosp La Fe, Expt Immunity Unit, E-46009 Valencia, Spain
来源：
HEPATOLOGY | 2009年 / 50卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
619
引用
收藏
页码：597A / 597A
页数：1
相关论文
共 50 条
  • [1] Worse Recent Efficacy of Antiviral Therapy in Liver Transplant Recipients with Recurrent Hepatitis C: Impact of Donor Age and Baseline Cirrhosis
    Berenguer, Marina
    Aguilera, Victoria
    Prieto, Martin
    Ortiz, Cecilia
    Rodriguez, Maria
    Gentili, Federico
    Risalde, Blas
    Rubin, Angel
    Canada, Raquel
    Palau, Antonio
    Rayon, Jose-Miguel
    [J]. LIVER TRANSPLANTATION, 2009, 15 (07) : 738 - 746
  • [2] EFFICACY OF ANTIVIRAL THERAPY IN LIVER TRANSPLANT RECIPIENTS WITH RECURRENT HEPATITIS C: EFFECT OF BASELINE CALCINEURINIC AGENT
    Rubin, Angel
    Aguilear, Victoria
    Berenguer, Marina
    Melero, Josep L.
    Ortiz, Cecilia
    Rodriguez-Soler, Maria
    Prieto, Martin
    [J]. LIVER TRANSPLANTATION, 2009, 15 (07) : S116 - S116
  • [3] Response to antiviral therapy in liver transplant recipients with recurrent hepatitis C viral infection: a single center experience
    Jain, Ashok
    Sharma, Rajeev
    Ryan, Charlotte
    Safadjou, Saman
    Kashyap, Randeep
    Mantry, Parvez
    Maliakkal, Benedict
    Orloff, Mark
    [J]. CLINICAL TRANSPLANTATION, 2010, 24 (01) : 104 - 111
  • [4] Efficacy and safety of antiviral therapy in liver transplant recipients with chronic hepatitis C
    Carrion, JA
    García-Retortillo, M
    Navasa, M
    Rimola, A
    García-Valdecasas, JC
    Forns, X
    [J]. JOURNAL OF HEPATOLOGY, 2005, 42 : 46 - 47
  • [5] Efficacy, predictors of response, and potential risks associated with antiviral therapy in liver transplant recipients with recurrent hepatitis C
    Berenguer, Marina
    Palau, Antonio
    Fernandez, Alberto
    Benlloch, Salvador
    Aguilera, Victoria
    Prieto, Martin
    Rayon, Jose-Miguel
    Berenguer, Joaquin
    [J]. LIVER TRANSPLANTATION, 2006, 12 (07) : 1067 - 1076
  • [6] Early predictors of antiviral treatment response in liver transplant recipients with recurrent hepatitis C genotype 1
    Campos-Varela, I.
    Esteban, J. I.
    Bes, M.
    Caralt, M.
    Allende, H.
    Rodriguez-Frias, F.
    Salcedo, M. T.
    Sauleda, S.
    Charco, R.
    Guardia, J.
    Esteban, R.
    Castells, L.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2014, 21 (10) : E118 - E128
  • [7] Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis
    Lake, JR
    Shorr, JS
    Steffen, BJ
    Chu, AH
    Gordon, RD
    Wiesner, RH
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (03) : 549 - 557
  • [8] Impact of donor age and year of transplant on graft survival in liver transplant recipients with chronic hepatitis C
    Russo, MW
    Galanko, JA
    Zacks, SL
    Beavers, KL
    Fried, MW
    Shrestha, R
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (07) : 1133 - 1138
  • [9] Anemia in liver transplant recipients undergoing antiviral treatment for recurrent hepatitis C
    Saab, Sammy
    Oh, Mina K.
    Ibrahim, Ayman B.
    Durazo, Francisco
    Han, Steven
    Yersiz, Hasan
    Farmer, Douglas G.
    Ghobrial, R. Mark
    Goldstein, Leonard I.
    Tong, Myron J.
    Busuttil, Ronald W.
    [J]. LIVER TRANSPLANTATION, 2007, 13 (07) : 1032 - 1038
  • [10] Effect of donor liver steatosis on progression of recurrent hepatitis C in liver transplant recipients
    Katabi, N
    Onaca, N
    Morkowski, J
    Thomas, M
    Goldstein, R
    Watkins, D
    Sanchez, E
    Levy, M
    Klintmalm, G
    Netto, G
    [J]. MODERN PATHOLOGY, 2003, 16 (01) : 279A - 279A
12345